Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Pluvicto Supply Shortage Update: How You Can Help

Compact, Low-Cost Lensless Radiomicroscope Developed for Nuclear Imaging

Listen to Part 2 of the Quantitative SPECT Podcast

Due to severe production issues, the supply of Pluvicto is not currently sufficient to meet patient need—and will not be until new production facilities are brought fully online. You can help. Please act now!

SNMMI is headed to the windy city this June 24-27 for the SNMMI 2023 Annual Meeting! Attend in person in Chicago or virtually from your home or office. Be part of the profession’s premier nuclear medicine & molecular imaging event. Learn more and register today.

A novel, palm-sized imaging modality can visualize the distribution of medical radiopharmaceuticals with very fine resolution, according to research published in March JNM. Known as the lensless radiomicroscope, the instrument offers the same level of imaging performance as its closest imaging equivalent but comes with significantly larger field of view and costs less than $100.

In part two of this SNMMI podcast, Dr. Stephen Graves and Dr. Benjamin Auer continue their discussion on quantitative SPECT, its use relative to PET imaging, requirements, and current status. Listen now or search "SNMMI Podcast Series" on your favorite podcast streaming platform to hear the latest episode.

SNMMI is excited to announce the release of the new MIRD Primer 2022: A Complete Guide to Radiopharmaceutical Dosimetry—a comprehensive, state-of-the-art guide to radiopharmaceutical dosimetry that reflects the dramatic evolution of the field of nuclear medicine, including molecular imaging and, increasingly, radiopharmaceutical therapy. Purchase your copy.

SNMMI NEWS

March 21, 2023 — New Compact and Low-Cost Lensless Radiomicroscope Developed for Nuclear Medicine Imaging
A novel, palm-sized imaging modality that can visualize the distribution of medical radiopharmaceuticals with very fine resolution has been developed and successfully tested, according to research published in March JNM. Known as the lensless radiomicroscope, the instrument offers the same level of imaging performance as its closest imaging equivalent but comes with significantly larger field of view and costs less than $100. (Press Releases)
March 20, 2023 — Update, Pluvicto Supply Shortage: How You Can Help
Due to severe production issues, the supply of Pluvicto is not currently sufficient to meet patient need. Please act now! (SNMMI News)
March 17, 2023 — SNMMI joins NIH Funding Support Letter
SNMMI joins with more than 370 member organizations represented by the ADHOC Group for Medical Research urging lawmakers to invest in the NIH, the newly established Advanced Research Projects Agency for Health (ARPA-H) program, as well as other agencies dedicated to advancing innovative treatments and therapies. (Government Relations News)
March 16, 2023 — Novel PET Radiotracer Successfully Detects Multiple Cancers, Offers Potential for New Targeted Radionuclide Therapy
A new radiotracer, Ga-68 FAP-2286, has been found to be more effective than the most commonly used nuclear medicine cancer imaging radiotracer, F-18 FDG, according to a study published in JNM. Ga-68 FAP-2286 detected 100 percent of primary tumors across multiple cancer types as compared to F-18 FDG, which identified only 80 percent. Ga-68 FAP-2286 was also more effective in detecting lymph node metastases and distant metastases. (Press Releases)
March 15, 2023 — President Biden Releases FY 2024 Budget Proposal
On March 9, President Biden released his FY 2024 budget proposal, which included $144.3 billion in discretionary funding and $1.7 trillion in mandatory spending. (Government Relations News)
March 13, 2023 — Advocacy Newsletter: Legislative and Policy Highlights
What to expect in 2023? Congressional Leadership and Committee Assignments; Cathy S. Cutler, PhD, presented at the recent CMS MEDCAC Meeting; Congressional Appropriations- DOD Funding; 2023 Robert E. Henkin Government Relations Fellowship. (Government Relations News)
March 8, 2023 — Pluvicto Supply Shortage Update: What SNMMI Is Doing
A supply problem with Pluvicto, the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients, which is having a profound negative impact on patient care. (SNMMI News)
March 6, 2023 — SNMMI Applauds Introduction of FIND Act of 2023: Legislation Will Ensure Patient Access to Innovative and Effective Diagnostic Imaging
SNMMI, along with more than 80 stakeholder organizations, supports and applauds the introduction of H.R. 1199, the Facilitating Innovative Nuclear Diagnostic (FIND) Act of 2023. The legislation will ensure patient access to innovative and effective diagnostic imaging. (Press Releases)

CONTINUING EDUCATION

New! ASNC/SNMMI 80 Hour Authorized User Training Course

The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »

New! SNMMI Qualified Systems Personnel Training Program (QSPTP)

The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »

SNMMI Webinars

Access upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »

Nuclear Medicine Online Review Course

Covering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »

Radiation Safety+ Review and Essentials

The Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »

CT+ Review and Essentials

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »

Member Benefit! Complimentary Journal SAMs/Journal CE

Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »

PUBLICATIONS

Journal of Nuclear Medicine

VIEW CURRENT ISSUE
Journal of Nuclear Medicine Technology

VIEW CURRENT ISSUE
Molecular Imaging
Journal

VIEW CURRENT ISSUE

FEDERAL LEGISLATIVE EFFORTS

The FIND Act – Learn more »

MOLECULAR IMAGING NEWS

March 22, 2023

UPCOMING EVENTS

Pacific Southwest Technologist Chapter (PSWTC) 2023 Spring Meeting
March 25, 2023 | 8-hour CEH (applied for) presented as a Hybrid program (in-person or virtual option) from beautiful Del Mar California. See Event Details ►
51st MECSNMMI Spring Meeting
April 14 – 16, 2023 | Educational sessions and exhibition- 19 CE available See Event Details ►
Hoag Annual Oncologic PET/CT and MIT Course
April 19 – 21, 2023 See Event Details ►

Tweets by SNM_MI

Featured Jobs from SNMMI's Career Center

Visit SNMMI's Career Center »

EDUCATION AND RESEARCH FOUNDATION

ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »